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ABSTRACT 
The Mystery of SP01 Delayed Early Genes 
by 
Tameson Kaye Snyder Yip 
Genes of the Bacillus subtilis infecting bacteriophage SPOl are classified as early, 
middle or late genes, based on which sigma factor is used for their transcription. 
Within the early gene category, there are two subsets of genes, immediate and 
delayed early (including genes 37-40), which have different temporal expression 
patterns. Genes 37-40 are shown involved in the shutoff of host macromolecular 
synthesis. Gene products (gp) 39 and 40 were shown to be lethal when expressed 
in E. coli cells, through an undetermined mechanism. Gp39 was purified under 
denaturing conditions, but could not be properly refolded. 
Genes 2.21, 25.1 and 51 were studied in order to understand how delayed early 
genes are regulated. Gp51 was partially purified. An additional gene expressed 
from within gene 51 was discovered. It was determined that SPOl mutations of 
genes 2.21 and 25.1 could not be isolated, even when a variety of conditions were 
tested. 
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Ch1: Background 
1.1 SP01 lifecycle- host takeover 
SP01 is a lytic, virulent bacteriophage that infects Bacillus subtilis (B. 
subtilis), a Gram-positive bacterium. When bacteriophages infect their 
host bacterium, they take over the host's DNA, RNA and protein synthetic 
abilities, making the host a factory for phage production. The host's 
synthetic processes are almost entirely shut off, removing competition for 
phage macromolecule production. The cells then produce the 
components for phage reproduction, such as phage DNA and phage 
capsids, which are then assembled into new phage. Lysins are produced 
to lyse the cells, allowing the phage to burst forth and find new bacteria to 
infect. The host takeover process is of interest as it requires highly 
specific mechanisms to allow for high levels of phage biosynthesis while 
shutting off most host DNA, RNA and protein synthesis. Several 
mechanisms involved in this process appear to be unique to SP01. 
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1.2 Non-SP01 Phage Host Takeover 
When a host cell is infected with a lytic phage, the host's macromolecular 
synthesis processes are almost entirely shut off, removing competition for 
phage macromolecule production. Even in a well-studied system like T4, 
which infects E. coli, the takeover process is not fully understood. As 
reviewed by Kutter, the shutoff of host translation is known to involve 
RegB endoribonuclease. However, regb mutants can still efficiently 
shutoff protein synthesis (Kutter et al., 1994). This indicates that more 
gene products (gps) must be involved though these are not yet 
understood. One of the proteins involved in host DNA replication shutoff 
is the protein Ndd (nuclear disruption), which acts by moving the genome 
away from the center of the cell and blocking replication (reviewed in 
Kutter et al., 1994). Meanwhile, the host RNA shutoff mechanism takes 
advantage of one of the unique qualities of T4. In the T4 DNA, 5-
hydroxymethyl cytosine replaces cytosine. The Ale protein prevents 
transcription from any DNA containing cytosine, shutting off host RNA 
synthesis specifically. Termination of transcription occurs at specific sites 
through interaction of Ale with the transcription complex. At the same time 
as these proteins are acting, T4 directed endonucleases II and IV degrade 
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cytosine containing DNA. The nucleotides are then used for phage DNA 
synthesis (reviewed in Kutter et al., 1994). 
T7 employs many different mechanisms to shut off host biosynthesis, 
some similar to T4, some very different. One different mechanism is the 
production of a T7 specific RNA polymerase (RNAP), allowing T7 to 
deactivate the host RNA polymerase. It does this though gp0.7 and gp2. 
Gp0.7 is a kinase which phosphorylates RNAP, while gp2 is an inhibitor 
that binds to RNAP. Other mechanisms used involve mRNA stability and 
protein stability. One mechanism similar to a T4 mechanism is the 
degradation of host DNA. A variety of phage gene products act to 
prevent restriction enzymes from degrading T7's DNA, while the host's 
DNA is degraded (Kruger and Schroeder, 1981). 
As currently understood, SP01 does not appear to use the same 
mechanisms. For example, in SP01, there is no host DNA degradation 
(Yehle and Ganesan, 1972). This is surprising as SP01 uses 
hydroxymethyl uracil instead of thymidine in its DNA, which would allow 
for clear distinction between SP01 and host DNA. As discussed in more 
detail throughout this work, many of the mutants of shutoff genes have 
unique phenotypes, not seen in other phage. SP01 also does not 
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produce its own RNAP, though it does produce its own sigma factors, 
discussed in detail below. Information about unique shutoff mechanisms 
and genes may be of practical use in designing new antibiotics. 
1.3 SP01 Gene Classification 
SP01 gene regulation heavily involves RNAP sigma factors. A sigma 
factor is a subunit in RNAP which confers specificity to RNA transcription. 
In SP01, genes are classified based on which sigma factor is required for 
their transcription: early genes use aA (a host sigma factor), middle 
genes use gp28 (an SP01 early gene), and late genes use gps33/34 (an 
SP01 middle gene) (see Table 1.1). SP01 infection begins with the 
transcription of early genes by aA, the B. subtilis sigma factor synthesized 
while the host is growing in exponential phase. These early genes are 
responsible for most of the host takeover process. One of these early 
genes specifies the sigma factor gp28, which causes transcription of the 
middle genes, which are responsible for phage DNA replication. Genes 33 
and 34 encode yet another sigma factor, which leads to transcription of 
late genes. Late genes code for the structural and morphogenic phage 
proteins (Fujita et al., 1971; Gage and Geiduschek, 1971; Losick and 
Pero, 1981; Talkington and Pero, 1977). 
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Table One: Gene Categorization 
Immediate Early Delayed Early Middle 
Expression Time 
(30C) 1-10 minutes 10-20 minutes 10-30 minutes 
Sigma factor B. subtilis A unknown SP01 gp28 
Representative 
genes 
48-49, 53-55, 56-58, 
44, 50-51 28, 37-39, 40 52, 31, TF1 
Table 1: Summary of Gene Classifications: Summary of the properties of 
Immediate Early, Delayed Early, Middle Genes, listing when the bulk of 
expression occurs, sigma factor used and representative genes. 
1.4 Delayed Early Genes 
While some genes can easily be classified as early, middle or late, other 
genes are more difficult to define. Early genes, for example, can be split 
into two categories: immediate early and delayed early. Genes 27-28 and 
37-40 are classified as delayed early genes. These genes are expressed 
later than immediate early genes, but, like the immediate early genes, do 
not rely on gp28. The role of genes 37-40 is not well understood, but it is 
believed that they are involved in the shutoff of host macromolecular 
synthesis. Understanding the role of the delayed early genes is critical for 
understanding the takeover process. 
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The regulation of immediate and delayed early genes is currently not 
understood. Both immediate and delayed early genes appear to use the 
same promoter, though there is some evidence, discussed below, that a 
different promoter may be required for delayed early gene expression. 
Currently, no transcription factors have been found that fully explain the 
differences in the timing of delayed early and immediate early expression. 
Genes 44 and 51 have already been shown to be involved in this process, 
but they do not play a causative role (Sampath and Stewart, 2004). 
Genes 25.1 and 2.21, recently discovered with the sequencing of the 
SP01 genome (Stewart et al, 2009), are potentially involved in the 
regulation of immediate and delayed early genes. 
1.5 Operon 37-40 
Genes 37-40 are delayed early genes, located in the terminal redundancy, 
in the host-takeover module, where 24 genes believed to be involved in 
host takeover are located. Host-takeover genes must be expressed early 
in infection, which fits with either immediate or delayed early genes. The 
promoter for the operon is very active, and the ribosome binding sites for 
each of the four genes are strong (Stewart et al., 1998). The 4 genes 
encode for protein of various sizes, from 31 amino acids for gp37, 190 
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amino acids for gp38, 255 amino acids for gp39 to 350 amino acids for 
gp40. Currently, BLAST searches using both amino acid and nucleic acid 
sequences have shown no significant matches between the four SP01 
gene products and the GenBank database, meaning that in order to make 
any hypotheses regarding their function, experimental data must be 
obtained. 
1.6 Genes 44, 50, 51 
Experiments using 
nonsense mutants of 
genes 44 and 51 show 
that these gene 
products regulate the 
shutoff of host RNA 
synthesis. These 
nonsense mutants were 
created by mutating a 
lysine early in the gene 
to a stop codon. In the 
51 nonsense mutant, gene 50 is also mutated. This is due to the 8 base 
Time (min.) 
Figure 1.1: Shutoff of host RNA synthesis. 
Rates of RNA synthesis were measured, by 
pulse-labeling with [5-3H] uridine, as a function 
of time after infection by the indicated strains. 
The graph shows TCA-precipitable kcpm; i.e. 
cpm X 10"3 (Stewart and Sampath, 2004). 
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overlap between genes 50 and 51. Due to gene 50's small size, 
specifying only 23 amino acids which form a single membrane spanning 
domain, we are focusing on gene 51. As shown in figure 1.1 (Sampath 
and Stewart, 2004), nonsense mutants of either gene 44 or 50/51 show 
decreased levels of total RNA (host and phage synthesis when compared 
with wild type (wt)). This indicates that SP01 is more effective at shutting 
off host RNA synthesis without these genes. Therefore, it is likely that 
these genes normally act to slow the shutoff process, indicating a 
regulatory role. 
In addition to genes 44 and 51's regulatory role, the mutants show that 
these genes are not essential for regulation of delayed early genes. The 
mutants were assayed looking at the RNA levels of individual genes 
(figure 1.1) (Sampath and Stewart, 2004). Strains of 44" and 50751" show 
higher expression compared to wild type for immediate early, delayed 
early and middle RNA expression. This eliminates genes 44 and 51 as 
the causative factor for delayed early gene expression, as a nonsense 
mutant of the causative factor would result in a knockout of delayed 
genes, not an increase in expression (Sampath and Stewart, 2004). While 
these gene products may be involved in the regulation, clearly another 
gene product must be involved. 
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While the 
Effect of Mutations on Gene Transcription 
M l c f l d l i 
individual 
knockout mutants 
show a negative 
regulatory role for 
gp 44 and 51, the 
Figure 1.2: Effect of Mutations on Specific Gene 
Transcription: RNA was harvested 15 minutes post 
infection for wt, 44-, 50-/51- and 44-/50-/51- SP01 
strains. The RNA was labeled and hybridized to dot 
blots on a positively charged nylon membrane, which 
was visualized on film. Amount of RNA was 
determined by densitometer. Relative amounts of 
RNA were determined by dividing the densitometer 
reading for each gene in an experimental strain by the 
reading for the gene in the wt strain. Genes are 
arranged based roughly on when their peak 
transcription occurred (data from Sampath and 
Stewart, 2004). 
triple mutant 44" 
50 51" indicates a 
potential 
stimulatory role for 
delayed early and 
middle gene 
expression. The 
triple mutant 
shows a decrease 
in expression of delayed early genes compared to the individual mutants 
and in some cases, a decrease compared to wild type. All middle genes 
tested showed an even more extreme decrease, with expression levels 
lower than wild type. This indicates that gp44 in the absence of gp51/50 
and gp51/50 in the absence of gp44 can stimulate delayed early and 
middle early gene expression (Sampath and Stewart, 2004). 
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A potential mechanism for gps44 and 51's regulatory effect is suggested 
by mutational analysis, binding assays and sequence homology. Gp44 is 
believed to bind to RNAP. When gp 44 is expressed in uninfected cells, 
the effect is lethal (Wei and Stewart, 1993). However, cells with a 
mutation in RNAP are protected from this lethal effect (Wei and Stewart, 
1995). This strongly suggests that RNAP and gp44 are binding partners. 
Furthermore, gp44 has been shown to bind to RNAP in in vitro studies 
(Severinov, 2006). Gps44 and 51 also include acidic hydrophobic 
domains which are similar to the domain required for E. coli CT54 to bind to 
RNAP (Tintut, et al, 1994). Genes 44 and 51 are expected to have similar 
functions as they share significant homology with each other (Stewart et 
al, 1998). The 44 and 51 mutants also share similar phenotypes, which 
strengthens the argument that both genes have the same target, RNAP. 
1.7 Gene 25.1 
Gene 25.1 may be involved in the regulation between immediate and 
delayed early genes. It has a putative early promoter and shares 33% 
and 34% identity with gps44 and 51 respectively (Stewart et al, 2009). As 
discussed above, gps44 and 51 are known to be transcription regulators. 
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More specifically, it has been shown that gps44 and 51, in the absence of 
each other, can stimulate delayed early and middle gene expression. 
With the high homology, it is possible that gp25.1 may also act in a similar 
positive regulatory manner. 
A second potential activity for gene 25.1 is indicated by the results for the 
44750751" triple mutant. The triple mutant shows higher expression of 
immediate early genes than wild type or either single or double mutant 
strain (Sampath and Stewart, 2004). This level is higher then expected for 
just the lack of a repressor. It is possible that gene 25.1 stimulates 
immediate early gene expression when genes 44 and 51 are not available. 
Based on homology, gps 25.1, 44 and 51 may all be able to bind with 
RNAP, so they may compete for binding. One potential mechanism could 
be that when gp25.1 binds to RNAP, it could cause immediate early gene 
expression, whereas when 44 and 51 are binding to RNAP, immediate 
early expression is repressed. 
1.8 Gene 2.21 
An additional sigma factor could also explain the regulation of delayed 
early genes. Gp2.21 is extremely interesting as it appears to be a sigma 
12 
factor. It shares 24% homology with CTK in B. subtilis and 31% homology 
with Clostridium perfringens' CTK (Stewart et al, 2009). CTK is expressed in 
B. subtilis only during sporulation. As SP01 can only effectively infect B. 
subtilis during the exponential phase, there is no concern that the B. 
subtilis CTK would affect the infection and takeover process. Delayed early 
genes, in addition to CTA promoters, have promoters that are similar to CTK 
promoters. If gene 2.21 is indeed an active sigma factor, which 
recognizes the CTK putative promoter, this could explain the difference in 
timing between the delayed and immediate early gene expression. 
Immediate genes could be expressed using CTA, while the delayed early 
are expressed using gp2.21. 
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Chapter 2: Materials and Methods 
2.1 Bacterial and Phage Strains 
Table 2.1 lists the bacterial and bacteriophage strains used in this work. 
2.2 Media and Growth Conditions 
LB, Penassay, VY (Difco) or NY (Difco) were used for growing cells in 
liquid. Cells were grown on plates made from 40 g/L Trypticase Soy Agar 
(TSA). Tryptose blood agar base (TBAB), at a concentration of 15.4 g/L 
or TSA, at a concentration of 12 g/L was used as top agar. Defined liquid 
media used were Spizizen's salts medium (SM) (Spizizen, 1958), C1 (SM 
plus glucose plus complete amino acids)(Stewart, 1969), C4 (C1 without 
leucine, isoleucine and valine, for E. coli 0.0204 mg/ml thiamine), C2 (SM 
plus 5% Casein Hydrolysate, glucose and 0.16 mg/ml Aromatic Amino 
Acids), and C3 (SM plus 4% glycerol, 0.4% glucose). Ampicillin (Amp), 
kanamycin (km) and carbenicillin were added to media at 50 |jg/ml. 
Chloramphenicol (cm) was added to the media for B. subtilis at 5 |jg/ml 
and 10 |jg/ml for E. coli. Isopropyl B-D-thiogalactopyranoside (IPTG) 
stock solution was prepared at 100 mM. 
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Table 2.1 Bacterial and Bacteriophage Strains 
Strain Relevant Genotype or Description Reference or Source 
Bacteria 
B. subtilis 
CB-10 his-trp-sup- Glassberg etal, 1977 
CB-313 his-met-sup3+ Glassberg etal, 1977 
E. coli 
DH5 
hsdR17 recA1 endA1 gyrA96 thi-1 
relA1 Sambrook etal, 1989 
Top Ten Maintenance strain for pET101 
Provided by Invitrogen Life 
Technologies 
BL21 STAR Contains IPTG inducible T7RNAP 
Provided by Invitrogen Life 
Technologies 
Rosetta 2 cells 
Expresses codons not typically 
expressed in E.coli 
Rosetta 2(DE3) Competent 
Cells for enhanced coverage of 
codon bias in E. coli (2003) 
inNovations 18, 28., provided 
by Novagen 
Bacteriophage 
SP01 wild type version 
SP01 37- nonsense mutation in gene 37 LL 
SP01 38- nonsense mutation in gene 38 
Laura Laughlin (LL) Stewart 
lab 
SP01 39- nonsense mutation in gene 39 LL 
SP01 40- nonsense mutation in gene 40 Bati Myles (BM) Stewart lab 
SP01 39-40-
nonsense mutation in genes 39 and 
40 LL 
SP01 38-39-
nonsense mutation in genes 38 and 
39 LL 
SP01 44-50-51-
nonsense mutation in genes 44, 50 
and 51 
Aruna Sampath (AS) Stewart 
lab 
SP01 40-44-50-51 
nonsense mutation in genes 40, 44, 
50 and 51 this work 
Table 2.1 Bacterial and Bacteriophage Strains: The table shows the 
different strains of bacteria and bacteriophage that were used throughout 
this work, as well as a brief description of them and the relevant reference. 
For strains created in the Stewart lab, the name of the creator is instead 
referenced. 
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In order to prepare SP01 lysates, a mid log phase B. subtilis culture was 
infected. The infected culture was shaken vigorously at 37°C until lysis 
occurred. The culture was then centrifuged in Sorvall RC-5B Centrifuge 
for 5 minutes at 5,000 rpm to remove cellular debris. 
2.3 Oligonucleotide primers and probes 
The oligonucleotides used in this work are defined in Table 2.2. 
Oligonucelotides were designed using the Amplify program and 
synthesized by Integrated DNA Technologies or Sigma Aldrich. 
2.4 Plasmids 
Plasmids were created by inserting genes into vectors pPW19, pET101 or 
pET28b (Table 2.3). The gene fragments were created by PCR using 
either SP01 or pBM1 (for genes 38-39) and PBM5 (for genes 37-39). For 
inserts cloned into pPW19, Hindlll sites were added through PCR. Hindi 11 
was used to cut the fragment and pPW19, by incubating at 37°C for one 
hour. Because both sides of the insert have Hindlll sites, the insert can 
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Table 2.2 Oligonucleotides 
Oligo 
name 
Sequence Brief 
Description 
Starting 
position 
Company 
Primers 
p37UT CACCGAACAAGG 
AGGGGTGTACAT 
GAGTG 
upstream of 
gene 37 
1804 IDTDNA 
p37DT GATTATCTCCTCC 
TCTTAATATACC 
downstream 
of gene 37 
1919 IDTDNA 
p783 CAGTTAAAGCTTT 
TACTGG I I IAGTT 
CCATATTGATTCC 
end terminal 
for gene 38, 
Hindlll site 
2474 IDTDNA 
pu277 CAAGGTGTGGCA 
TAATGTGTGGAAT 
TGTGAGC 
upstream of 
insert in 
pPW19 
277 in 
pPW19 
IDTDNA 
p39UT CACCCCGGCACC 
TTAATGAGGAAT 
upstream of 
gene 39 start 
site, used for 
Topo cloning 
2386 IDTDNA 
p1559 CGCATAAAGCTTA 
TACCCCTTTCTTA 
GGCACTAGTGG 
downstream 
of gene 39, 
Hindlll site 
3250 IDTDNA 
39DTM TACCCCTTTCTTA 
GGCACTAGTGGA 
G 
downstream 
of 39 with 
end terminal 
tag removed 
to allow his 
tag 
expression 
3250 IDTDNA 
p28B/39F ATCGAGCCATATG 
ATGGAACTAAACC 
TAGA 
upstream of 
gene 39 for 
cloning into 
pET28B, 
Ndel site 
2482 IDTDNA 
P28b/39R AGACTGAAGCTTT 
TATACCCCI I ICT 
TAGGCACATTT 
downstream 
of gene 39 
for cloning 
into pET28B, 
Hindlll site 
3250 IDTDNA 
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p40DT GGGTATCAGTCTT 
CAGTTTGCTCTAC 
downstream 
of gene 40 
4309 IDTDNA 
p40UT CACCCTCCACTAG 
TGCCTAAGAAAG 
GGG 
upstream of 
gene 40 
3223 IDTDNA 
40DTM GTCTTCAGTTTGC 
TCTACTCGC1 1 1 1 
CTATGTCC 
downstream 
of 40 with 
end terminal 
tag removed 
to allow his 
tag 
expression 
4301 IDTDNA 
6070 CAGTTAAAGCTTG 
TTCTCCTCATAAG 
downstream 
of 2.21, 
Hindlll site 
26070 IDTDNA 
5332 ACGTAGAAGCTTG 
ATGGGACGAGGA 
GTGGGG 
upstream of 
2.21, Hindlll 
site 
25332 IDTDNA 
5009 ACG TAG AAG 
CTT GGT GGG 
AAG CGG GCT 
AAG AAA CTA 
GGT C 
upstream of 
2.21, Hindlll 
site 
25009 IDTDNA 
8292 ACA CTC AAG CTT 
TGT AAT AAT TTG 
TTC AGG GCA 
AGA GG 
upstream of 
25.1, Hindlll 
site 
88292 IDTDNA 
8990 ACA CTC AAG CTT 
CCG CAG TTC 
CCC CAT GTT 
GCT TGT C 
downstream 
of 25.1, 
Hindlll site 
88990 IDTDNA 
8264 ACG TAG AAG 
CTT 1 1 1 TCT GTG 
GAA TGG GGC 
AAA ATG ACT TCA 
ACA G 
upstream of 
25.1, Hindlll 
site 
88264 IDTDNA 
18 
2.21TAGm 
ut 
GGT CTA TAT TTA 
CAC TAG ATG 
AGT GTA AAA 
AGG GAT GAA GG 
primer used 
to mutate 
2.21wtA 
25378 IDTDNA 
2.21 TAGm 
utRC 
CCT TCA TCC CTT 
I I I ACACTC ATC 
TAG TGT AAA TAT 
AGA CC 
primer used 
to mutate 
2.21wtA 
25418 IDTDNA 
2.21TAA GAT GGG ACG 
AGG AGT GGG 
GAA AAT GTC TCA 
AAC TAA ATA AGA 
TGT AGG TCT ATA 
TTT A CAC 
used to 
mutate 
p2.21wtB 
25332 Sigma 
Aldrich-
PAGE 
purified 
2.21TAAR 
C 
GTG TAA ATA TAG 
ACC TAC ATC TTA 
TTT AGT TTG AGA 
CAT TTT CCC CAC 
TCC TCG TCC CAT 
C 
used to 
mutate 
p2.21wtB 
25390 Sigma 
Aldrich-
PAGE 
purified 
25.1 TAGm 
ut 
ATG ATG GCA TAT 
GAA GTA GAA 
GGA TAG GTA 
GTT AGT ACT CTT 
AAG GAA CTA 
Used to 
mutate 
p25.1wtA 
88353 IDTDNA 
25.1TAGR 
C 
TAG TTC CTT AAG 
AGT ACT AAC TAC 
CTA TCC TTC TAC 
TTC ATA TGC CAT 
CAT 
Used to 
mutate 
p25.1wtA 
88403 IDTDNA 
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25.1TAA GAA AGA TCT 
AAG TGA GGG 
TGG TTA ATT CCA 
TGA TGT AGT GTC 
TTT GGT TGA TGC 
Used to 
mutate 
p25.1wtB 
88427 Sigma 
Aldrich-
PAGE 
purified 
25.1TAA 
RC 
GCA TCA ACC 
AAA GAC ACT ACA 
TCA TGG AAT TAA 
CCA CCC TCA CTT 
AGA TCT TTC 
Used to 
mutate 
p25.1wtB 
88427 Sigma 
Aldrich-
PAGE 
purified 
Probes 
2.21(5393) 
mut 
CACTCACTATGTG 
TAAATAT 
probe used 
to detect 
p2.21wtA 
25393 IDTDNA 
2.21(5393) 
wt 
CACTCATTTTGTG 
TAAATAT 
probe used 
to detect 
p2.21mutA 
25393 IDTDNA 
2.21(5360) 
mut 
CAA ACT AAA TAA 
GAT GTA GGT C 
probe used 
to detect 
2.21 mutB 
25360 IDTDNA 
2.21(5360) 
wt 
CAA ACT AAA AAG 
GAT GTA GGT C 
probe used 
to detect 
2.21wtB 
25360 IDTDNA 
25.1(8377) 
mut 
GAAGGATAGGTA 
GTTAGTAC 
probe used 
to detect 
25.1wtA 
88377 IDTDNA 
25.1(8377) 
wt 
GAAGGAAAAGTA 
GTTAGTAC 
probe used 
to detect 
25.1 mutA 
88337 IDTDNA 
25.1(8449) 
wt 
GGG TGG TAA 
GTT CCA TG 
probe used 
to detect 
25.1 mutB 
88449 IDTDNA 
25.1(8449) 
mut 
GGG TGG TTA 
ATT CCA TG 
probe used 
to detect 
25.1 wtB 
88449 IDTDNA 
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LYS3UAG AAATGGCTUAGTC 
AAATAA 
probe used 
for 44-
screening 
5886 IDTDNA 
LYS3AAA AAATGGCTAAATC 
AAATAA 
probe used 
for 44 wt 
screening 
5886 IDTDNA 
40mut GGGGACTCAAAT 
ACG 
probe used 
for 40-
screening 
3271 IDTDNA 
40wt GGGGACTCTAGT 
ACG 
probe used 
for 40 wt 
screening 
3271 IDTDNA 
Table 2.2 Oligonucleotides: The oligonucleotides, used either as 
primers or probes throughout this work are defined. After the name of the 
primer, the sequence (5' to 3') and a brief description of the 
oligonucleotide are given. The location of the start site of the sequence in 
SP01, or a plasmid where noted, is given. 
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Table 2.3 Plasmids 
Plasmid Vector Insert 
Reference/ 
Creator 
Primers 
used 
PCR 
template 
PET28B Novagen 
PET101 
Studier, et al, 
1990; 
obtained from 
Invitrogen Life 
Technologies 
pPW19 
Wei and 
Stewart, 1993 
pET101lacZ pET101 
lacZ gene, 
used as 
control Invitrogen 
pBM1 pPW19 
genes 38-40 
in expressed 
orientation, 
gene 40 is 
interrupted by 
insertion BM 
pBM5 pPW19 
37-39 in 
unexpressed 
orientation BM 
pAZ51 pET101 
51 with c-
terminal his 
tag 
Antonin 
Zwiefka (AZ), 
Stewart lab 
pPW19lacZ pPW19 
pPW19 with 
lacZ gene-
used as 
control 
Maurie Mintz 
(MM), Stewart 
lab 
pTY37 PET101 
37 in 
expressed 
direction TY 
p37UT, 
p37DT pBM5 
pTY38F pPW19 
38 in 
expressed 
direction 
Tameson Yip 
(TY) Stewart 
lab 
p783, 
pU276 pBM1 
pTY38R pPW19 
38 in 
unexpressed TY 
p783, 
pU277 pBM5 
pTY39 PET101 
39 expressed, 
no his tag TY 
p39UT, 
p1559 pBM1 
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pTY39C pET101 
39 in 
expressed 
direction with 
his tag added 
to c-terminal 
end TY 
p39UT, 
39DTM pBM5 
PTY39N pET28B 
pET28B with 
gene 39 
inserted with 
N-terminal his 
tag TY 
p28B/39F, 
P28B39R pBM1 
pTY40 PET101 
gene 40 in 
expressed 
direction TY 
p40UT, 
p40DT wt SP01 
TY40his pET101 
40 in 
expressed 
direction with 
his tag added 
to c-terminal 
end TY 
p40UT, 
40DTM wt SP01 
p25.1 wtA pPW19 
25.1 in 
expressed 
orientation TY 
8292, 
8990 SP01 
p25.1 mutA pPW19 
25.1 mutated 
in expressed 
orientation TY 
25.1 starting 
after -35 site, 
in 
unexpressed 
orientation p25.1wtB pPW19 TY 
8264, 
8990 SP01 
p25.1mutB pPW19 
mutated 25.1 
starting after -
35 site, in 
unexpressed 
orientation TY 
p2.21wtA pPW19 
2.21 in 
unexpressed 
orientation TY 
5332, 
6070 SP01 
2.21 mutated 
in 
unexpressed 
orientation p2.21 mutA pPW19 TY 
23 
p2.21wtB pPW19 
mutated 2.21 
with 345 
upstream 
bases in 
unexpressed 
orientation TY 
5009, 
6070 SP01 
p2.21 mutB pPW19 
2.21 with 345 
upstream 
bases in 
unexpressed 
orientation TY 
Table 2.3 Plasmids: This table outlines the plasmids used throughout 
this work. References are given for plasmids created outside the lab. 
Plasmids created by the lab are listed with the creator. The vector refers 
to which vector the insert was cloned into. For plasmids I created, the 
primers used for amplifying DNA for the insert, as well as the PCR 
template, are also listed. 
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clone into the vector in either direction. When the gene is cloned so that 
its expression is under control of the vector's promoter, the insert is 
considered to be in the expressed direction. When the gene is in the 
opposite direction, it is considered to be in the unexpressed orientation. 
For pET28b, a Hindlll site downstream and an Ndel site upstream were 
added through the PCR primers. Ndel and Hindlll plus buffer II [New 
England Biolabs (NEB)] were then added to the PCR fragment and the 
template and incubated for one hour at 37°C. The fragment was then 
ligated to pPW19 or pET28b by incubating the digested plasmid, the 
digested fragment and T4 DNA ligase (Roche) overnight at 16°C or at 
37°C for 3 hours. The ligase reaction was deactivated by heating to 65°C 
for ten minutes. Ligation mixture was stored at 4°C until transformation, 
which was performed within 24 hours. pET101 was purchased from 
Invitrogen and uses the Topo system to incorporate a PCR insert 
(Invitrogen). A 6X C-terminal his tag can be added to a gene product by 
removing the stop codon with mutated primers. Plasmids were purified 
using Qiagen or MoBio kits, as described by the manufacturers. Table 2.3 
shows the plasmids used throughout this work, with the insert and the 
primers used to create them. 
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2.5 DNA Transformation 
DH5 and Rosetta2 cells were made competent through chemical means. 
Cells were grown overnight at 37°C and then diluted 1:100. The culture 
was allowed to grow to Klett 25-30 and then the cells were chilled on ice 
for 10 minutes. Cells were centrifuged for ten minutes at 5000 rpm at 4°C. 
The supernatant was discarded and the pellet resuspended in 25 mis of 
50 mM CaCl2. After incubating on ice for one hour, the cells were 
centrifuged for ten minutes at 3000 rpm at 4°C. The supernatant was 
again discarded and the pellet was resuspended in 3 ml of 50 mM 
CaCl2/20% glycerol. The cells were either used immediately or stored 
immediately at -80°C. Top Ten and BL21 Star competent cells were 
purchased from Invitrogen. 
Lab prepared competent cells were transformed by adding 5 pis of DNA to 
200 |jls of competent cells. Tubes of competent cells were incubated on 
ice for 30 minutes and then heat shocked at 42°C for 45 seconds. They 
were then immediately put in ice for 2 minutes. 1 ml of LB was added and 
the cells were incubated for 1 hour at 37°C. The cells were then plated 
and plates were grown overnight at 37°C. Top Ten and BL21 Star cells 
were transformed according to manufacturer's protocols (Invitrogen). 
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B. subtilis cells are naturally competent under starvation conditions. In 
order to transform them, an overnight culture was grown in 10 mis of 
Penassay with 0.1 ml 40% glucose, using a cotton plug. These were 
grown for 12-13 hours in a 37°C water bath with slow shaking. The cells 
were centrifuged for 5 minutes at 5000 rpm and then resuspended in 0.1 
volume of SM with Amino Acid mix. 0.2 mis of the resuspended culture 
were diluted into 20 mis of C-1. Cells were grown until the culture was out 
of the exponential phase. This was determined by plotting the Klett 
reading versus time on a semi log graph. When the growth begins to level 
off, the cells are leaving exponential phase. The culture was then added 
to 80 mis of C2 and grown at 30°C with very slow shaking for 2 hours. For 
every 100 mis of competent cells, 1 ml of 2M MgCI2 and 1 ml of 40% 
glucose were added. To transform the now competent cells, 1.0 |jg of 
DNA was added to 1.0 mis of competent cells. Cells were grown at 37°C 
with normal shaking for 2 hours and plated on antibiotic plates for 
selection. 
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2.6 Polymerase Chain Reaction 
When using SP01 as a template, Taq polymerase (Eppendorf) was used: 
for all other reactions, Pfu (Stratagene) was used. dNTPs (Stratagene) 
were used at 0.2 mM concentration. All reactions were performed in a MJ 
Research MiniCycler. 0.05|jg/|jl of each primer was added. For SP01 
templates, the following program was used: 
A: 94°C for 2 minutes. 
B: 5 cycles of 3 segments each: 
94°C for 30 seconds 
44°C for 30 seconds 
72°C for 2 minutes 
C: 30 cycles of 3 segments each 
94°C for 30 seconds 
50°C for 30 seconds 
72°C for 2 minutes 
D: 72°Cfor 10 minutes 
E: 15°C forever 
For thymidine templates, the following program was used: 
A: 94°C for 2 minutes. 
B: 30 cycles of 3 segments each 
94°C for 30 seconds 
50°C for 30 seconds 
72°C for 2 minutes 
C: 72°Cfor 10 minutes 
D: 15°C forever 
When the program states forever, that indicates that the program will hold 
the temperature until the user provides further input. 
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2.7 DNA, RNA and Protein Synthesis Assays 
Macromolecular synthesis can be measured by pulse labeling. In order to 
label the synthesized macromolecules, for protein synthesis 4.0 pCi/ml 
H3-leucine (MP Biomedicals) was used, for RNA, 4.0 pCi/ml 5 H3-uridine 
(MP Biomedicals) was used, and for host DNA 4.0 pCi/ml H3-thymidine 
(MP Biomedicals) was used. Because SP01 uses hydroxymethyl uracil 
instead of thymidine, this allows for testing phage and DNA synthesis 
separately. For RNA synthesis, during SP01 infection, for the first 25 
minutes of infection, the bulk of RNA synthesized is host RNA. Cultures 
were grown in C4 medium, which does not include leucine or DNA 
precursors. This encourages incorporation of the radioactively labeled 
precursors into the newly synthesized molecules. 
When looking at the effect of expression of a gene on a bacterial cell, a 
bacteria culture containing the plasmid that expresses the specified gene 
was grown to the desired concentration. Experiments were performed 
with expression beginning at Klett 50, 15 or 1.5. For experiments where 
the culture was induced at Klett 1.5, the cultures were grown to Klett 15 
(early exponential phase) and then diluted 1:10. Gene expression was 
induced using 1 mM IPTG and unless otherwise stated, cells were grown 
at 37°C with shaking at 100 rpm. Figure 2.1 shows an overview of a 
single pulse measuring DNA synthesis. At varying times, an aliquot of 0.5 
Infected 
culture 
Precipitate DNA & 
pour through filter 
Figure 2.1 DNA Pulse: A cartoon representation of a DNA 
pulse is shown. An aliquot of the induced or infected culture is 
added to radioactively labeled DNA precursor. Newly 
synthesized DNA will include the radioactive precursor. The 
solution is then precipitated and poured over a filter. The DNA 
does not pass through the filter, but the unincorporated 
radioactive precursor does. The filter is then measured for 
radioactivity, which represents how much DNA synthesis 
occurred in the 5 minute pulse. Figure created by Laura 
Laughlin. 
mis of the culture was added to 0.1 ml of the appropriate radioactive 
precursor. Incorporation of the precursor was allowed to proceed for five 
minutes and then the macromolecule was precipitated by adding 10% 
TCA. For the precipitates measuring protein synthesis, the precipitate 
was first boiled for 15 minutes and then cooled on ice for a minimum of 10 
minutes. For all others, the precipitate was stored briefly on ice, for no 
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more then two hours. The precipitate was then run through a 0.45 micron 
nitrocellulose filter that collects the radioactive macromolecule, while 
allowing the unincorporated radioactive molecule to flow through. The 
filters were individually washed with 30 mis of cold 0.3% TCA in DSC 
(0.015 M NaCI, 0.0015 M NaCitrate). The radioactivity of the filter was 
then measured, determining the rate of synthesis. Measuring was 
performed by placing the dried filter into a filmware bag with 1 ml of 
scintillation fluid and then counting using a scintillation counter. 
In order to determine the phenotype of the nonsense mutants, a similar 
process was followed. CB10 cells were grown to mid- exponential phase 
and then the culture split into smaller aliquots. This allows for comparison 
between wild type and mutant strains with an essentially identical starting 
point. The CB10 cells were infected with 5x108 phage/ml, leading to a 
multiplicity of infection (MOI) of approximately 5. Five minute pulses were 
performed at varying times after expression. Cultures were also plated to 
determine the MOI immediately prior to infection and 5 minutes post 
infection. 
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2.8 Colony Formation Assay 
Bacteria containing plasmids expressing SP01 genes were grown to mid 
exponential phase. The genes were then induced by adding 1 mM IPTG. 
At different times after gene induction, samples of the colony were plated 
on antibiotic TSA plates in duplicate. The colonies on each plate were 
counted and the two plates averaged. In order to insure that plates with a 
low enough concentration of colonies were obtained, the colonies were 
plated at multiple dilutions. When plates from multiple dilutions were 
countable, the lowest dilution plates were used. 
2.9 Isolation of gp38-Resistant and gp39-Resistant E. coli strains 
Expression of genes 38 and 39 led to deficient growth. Bacteria 
containing either pTY38F or pTY39 were plated on antibiotic TSA plates 
containing IPTG. The plates were grown overnight at 37°C. Colonies that 
were capable of normal growth were selected as potential mutants. In 
order to determine if the mutations were in the plasmid, the plasmid was 
purified with the Qiagen rapid plasmid prep, following the manufacturer's 
protocol. The purified plasmids were transformed into wild type cells and 
plated on plates with and without IPTG. If the lethal effect was still 
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present, it was assumed that the mutation was within the cell's 
chromosome. If the plasmid had mutated, then the cells would grow 
equally well on plates with or without IPTG. If the mutation was 
chromosomal, the cells were then cured of the plasmid by growing a 
culture at 37°C, with normal shaking, diluting as necessary, for several 
days. In order to determine if the cells were cured, the culture was plated 
on plates without antibiotics and grown overnight. Individual colonies 
were then streaked onto plates with and without the appropriate antibiotic. 
When the colony has lost its plasmid, it will no longer be resistant to the 
antibiotic. If the streak did not grow on the antibiotic plate, but did grow on 
the plate with no antibiotic, that colony was considered cured. 
Since the pET101 expression system requires expression of T7 RNAP 
from the cell's genome, it is possible that a cellular mutation would disable 
expression of T7 RNAP. This would disable expression of any gene from 
the plasmid and would not be a useful mutation to isolate. To test for 
chromosomal mutations in T7 RNAP, the cured bacterial culture was then 
transformed with pAZ51, a plasmid expressing gene 51, which was 
previously shown to be highly lethal. The transformed cells were grown 
on plates with IPTG. If the culture was resistant to the effects of this gene, 
it was assumed that the mutation was not specific to gene expression. A 
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plasmid expressing lacZ was also used to screen for mutations which 
disabling gene expression from the plasmid. These cultures were plated 
on plates containing X-gal. Colonies unable to express the gene would be 
white (instead of blue), indicating that the colony was not resistant to the 
expressed gene. None of our potential resistant mutants passed all tests. 
2.10 Plaque and Colony Lifts 
DNA can be lifted from TSA plates containing either plaques or bacterial 
colonies. Plaques or colonies were lifted from the plates onto S&S BA85 
Protran membranes (Schleich and Shuell). Membranes were gently laid 
directly onto the plates and removed when the full surface area was wet. 
These filters were then exposed to 0.5 N NaOH/1.5 M NaCI by placing the 
filter onto 3MM paper saturated with the solution. After 5 minutes, the 
filter was moved to 3MM paper saturated with 1.0 M Tris pH 7.4 and then 
moved to 3MM paper saturated with 0.5 M Tris pH 7.4. The DNA was 
then UV crosslinked to the membrane using the Stratagene UV 
Stratalinker. 
2.11 Isolation of 4044-50-51 SP01 Mutation 
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A culture of B. subtilis CB313, a suppressor strain, containing the plasmid 
pJT3 (pPW19 with mutated gene 40) was infected with 44"50"5rSP01 
(created by Aruna Sampath) at a MOI of one. When phage infects the 
CB313 with the plasmid, the phage DNA and the plasmid are capable of 
homologous recombination, effectively transferring the mutation from the 
plasmid to the phage. Fifteen minutes after infection, the infected cells 
were diluted 1:50. After 45 minutes, 0.2 mis of chloroform per 10 ml of 
infected culture was added to the diluted culture. The lysate was then 
plated for plaques by adding CB313 grown to mid exponential phase, and 
the ysate to15.4 g/L TBAB top agar. Plates were grown overnight at 37°C, 
then moved to room temperature for 8-24 hours. They were then stored at 
4°C for 1-4 days and plaques lifted as described in Ch 2.10. 
Oligos 40wt15 and 40mt15 were labeled with flourescein 11-dUTP. 5.32 
pis Cacodylate buffer, 3.325 pis Flourescein 11-dUTP, 1.7 pis of 0.1 pg/pl 
oligo in 10 mM Tris 7.4 buffer, 2.7 pi terminal tansferase and 40.2 pis of 
H2O (Amersham Biosciences) were mixed in a microcentrifuge tube with a 
pipette tip. The solution was incubated for 90 minutes at 37°C. The 
labeled probes can be stored at -20°C for up to one month or used 
immediately. 
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Membranes were placed into the hybridization tubes with 6.6 mis of 
hybridization buffer (25.2 ml H20, 30 ml CSC, 0.6 ml 10% SDS, 3 ml 
liquid buffer, 300 mg dextran sulfate MW 500000). The tubes were 
incubated in Robbins Scientific Model 400 Hybridization incubator for 60 
minutes at 27°C, rotating at 4 rpm. For each membrane, 16 pis of labeled 
oligo were added to the tube. Tubes were rotated overnight. The 
hybridization solution was discarded and the membranes washed with 20 
mis of 5X SSC/0.1 % SDS. The membranes were moved to a glass pan 
and 536 ml of 5XSSC/ 0.1 % SDS were added. After 5 minutes of gently 
shaking, the solution was removed. This wash step was repeated once. 
The membranes were then washed with Buffer 1 (17.5g NaCI, 4.72g Tris 
base, 25.4g Tris HCI, 2000 ml H20) for 1 minute. For each membrane, 
13.2 mis of 1:20 liquid block (Amersham Biosciences) was added and 
then incubated at room temperature on a rotary shaker at 100 rpm for 30 
minutes. Membranes were rinsed with 636 ml buffer 1 for 1 minute. The 
buffer was then discarded and then, for each filter, 15 mis of antibody 
solution [5 mg/ml BSA with 1:100 antiflourescein HRP conjugate mixed in 
buffer 2 (46.8g NaCI, 4.72g Tris base, 2000 ml H20)] was added. The 
membranes were then incubated for 30 minutes on a rotary shaker at 100 
rpm. Membranes were washed with 636 ml buffer 2 twice for 5 minutes. 
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To detect the signal, 3.5 mis of Detection solution 1 were mixed with 3.5 
mis of Detection Solution 2 from the ECL Detection Reagents (Amersham 
Biosciences). 6.6 mis of mixed detection solution were distributed onto 
the membranes evenly. After one minute of incubation, the membranes 
were drained by touching the membrane to 3MM paper and then wrapped 
in Saran Wrap. Film was exposed to the wrapped membranes for a 
minimum of 9 hours and then developed. 
Plaques that tested positive were picked and resuspended in 1 ml 
Penassay. The resuspended single plaque was then plated. These 
plates were tested in the same manner as in the original screening 
experiment. Since the mutation is in the terminal redundancy, an 
originally positive plaque will lead to plaques with 2 mutant copies of the 
gene, 1 mutant and 1 wild type copy of the gene or 2 wild type copies of 
the gene. For this reason, both a primary and a secondary lift were 
performed from the putative mutant plate and probed with either wild type 
or mutant probe. A plaque where the DNA hybridizes successfully to just 
the mutant probe and not the wild type probe was considered 
homozygous for the mutation. Sequencing was performed by Lonestar 
Labs to confirm the mutation. 
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Ch 3: Role of Genes 37-40 
In order to understand the role of genes 37-40, two different approaches 
were used: nonsense mutants and gene expression in uninfected cells. 
Nonsense mutants were created by mutating a lysine codon early in the 
gene to a stop codon. Mutant phage lysates were then used to infect 
CB10 B. subtilis and the infections monitored. Pulse labeling, described in 
Ch 2.7, was used to monitor the biosynthesis of host DNA, total RNA, and 
total protein. By comparing the rate of macromolecular synthesis between 
the mutant strains and the wild type strain, the effect of the genes on host 
shutoff can be determined. For example, if shutoff of DNA synthesis is 
deficient in a mutant strain, then it is likely that the gene product plays a 
causative role in host DNA synthesis shutoff. If shutoff of DNA synthesis 
is accelerated in the mutant strain, then the gene probably acts to restrain 
host DNA shutoff. 
The second approach to determining the effect of the gene products was 
to express the gene in uninfected bacterial cells. The gene was cloned 
into either pPW19 or pET101, which put the genes under control of an 
IPTG- inducible promoter. After gene expression is induced, colony 
formation assays (Ch 2.8) and pulse labeling (Ch 2.7) experiments are 
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performed. Since these genes are believed to be involved in the shutoff of 
host RNA, DNA or protein, it is expected that expression will be 
detrimental and most likely lethal to the cell's growth. This assumes that 
the gene products can bind to bacterial cell targets and carry out their role 
without other SP01 genes or cofactors. Since gene expression did show 
a detrimental and, for genes 39 and 40, lethal effect, macromolecular 
synthesis, measured by using pulse labeling, was performed. It was 
hoped that these experiments would more precisely explain the role of the 
gene product. For example, if the gene product is involved in shutting off 
DNA synthesis, when the gene is expressed, the amount of DNA being 
produced should drop. The last experiment performed using the 
expression plasmids was a simple plating assay. The cultures were 
plated on inducing plates and grown at 37°C. This experiment provides 
the least specific information, as the lack of growth could indicate a 
biostatic effect or a lethal effect and it gives no quantitative data regarding 
the growth rate. However, it is useful to quickly determine if gene 
expression has any effect on the cells. 
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3.1 Gp 40 plays an essential and causative role for the normal shutoff 
of host RNA and DNA synthesis. 
Figure 3.1. Shutoff of Host DNA 
Synthesis 
5 10 15 20 
Time (Minutes) 
Figure 3.1: Shutoff of host DNA 
synthesis (39 ,40", 39"40 ). Rates 
of DNA synthesis were measured, 
by pulse-labeling with [methyl-3H] 
thymidine, as a function of time 
after infection by the indicated 
strains. The graph shows TCA-
precipitable kcpm; i.e. cpmXIO"3. 
Error shows a representative set of 
data and was reproduced 
numerous times. Data produced by 
Bati Myles. 
Figures 3.1 and 3.2 clearly 
show that gene 40 knockout 
mutants are deficient in both 
RNA and host DNA synthesis 
shutoff (Bati Myles, Laura 
Laughlin data). When the wild 
type strain infected CB10, 
within 5 minutes host DNA 
shutoff had begun, as shown 
by the significant decrease in 
the rate of DNA synthesis. By 
12 minutes shutoff was nearly 
complete. When the 40" strain 
infects CB10, there was a 
small decrease in the rate of 
DNA synthesis after 5 minutes, 
but the amount of synthesis was still greater than wild type. By 12 
minutes, the difference in shutoff was even more dramatic, with the 40" 
40 
strain synthesizing more DNA than the wild type strain, throughout 
numerous repetitions of the 
Figure 3.2 ShutofT of Host RNA Synthesis 
0 5 10 15 20 
Time (Minutes) 
Figure 3.2: Shutoff of host RNA 
synthesis (40% 38 39-, 38 39 40"). 
Rates of RNA synthesis were 
measured, by pulse-labeling with [5-
3H] uridine, as a function of time after 
infection by the indicated strains. 
The graph shows TCA-precipitable 
kcpm; i.e. cpm X 103. Graph shows 
representative data. Data produced 
by Laura Laughlin. 
experiment. At 25 minutes, the 
40" strain had significant 
shutoff, but still produced over 
twice as much DNA as the wild 
type strain. This indicates that 
some DNA shutoff can still 
occur without gp40; however, 
gp40 is essential for complete 
shutoff of host DNA to occur. 
For the shutoff of host RNA 
synthesis, by 24 minutes, RNA 
levels from 40" infected cells 
were similar to those in wild type; however at 5 and 12 minutes, there was 
significantly more RNA synthesis in the 40" strain. This indicates that gene 
40 is essential and causative for the shutoff of RNA, but it is not the only 
gene involved in the process. 
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The dual function of gp40 (without genomic degradation) appears to be 
unique to SP01. We do not believe that the shutoff of RNA synthesis 
leads to the shutoff of DNA synthesis or vice versa. While the timing of 
the experiments is not precise enough to say conclusively that one shutoff 
does not cause the other, the intervals between the time points are 
relatively short make this unlikely. It has been shown that when RNA 
synthesis is shutoff in E.coli, the resulting shutoff in DNA synthesis occurs 
very slowly, at rates where the causation would be clear under our 
experimental conditions (Lark, 1972). Furthermore, in other nonsense 
mutants, such as 39" and 44 50 51", RNA and DNA synthesis have 
different phenotypes. If the shutoffs were connected to each other, the 
mutants would have a similar phenotype for both types of shutoff, as the 
effect on one shutoff would cause a similar effect on the other shutoff. 
3.2 Gene 40 expression in uninfected cells causes varying degrees 
of lethality in E. coli. 
The gene 40 mutants indicate a causative role in host RNA and DNA 
synthesis shutoff. However, when gene 40 was expressed in uninfected 
cells, the effect varies greatly, depending on the conditions. Under 
several conditions, there was no difference in gene 40 expression and 
expression of a lacZ control (referred to as BG) (figure 3.3). When gene 
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40 was expressed in cells induced at Klett 1.5 and grown in C4 medium, a 
clear lethal effect was seen (figure 3.4). Under these conditions, the 
Figure 3.3: Cellular Growth With 
Gene Expression Induced at 
Klett50. Liquid cultures of BL21 
STAR containing pTY37, pTY39, 
pTY40 or pET101 lacZ, grown to 
Klett50 in LB media, were plated on 
non-inducing plates immediately 
before gene induction and then 
every hour for three hours. The 
number of colonies on each plate 
was counted and divided by the 
number of colonies on the initial 
plates. Numbers greater than one 
indicate continued growth. 
Numbers less than one indicate cell 
death. B-gal is a control containing 
pET101lacZ. Data shows 
representative data from 3 
experiments. 
control strain barely grew, indicating 
that these were harsh conditions for 
this strain. Since the cells were already 
Figure 3.4: Cellular Growth With 
Gene Expression Induced at 
Klettl .5. Liquid cultures of pTY39, 
pTY40 or pET101 lacZ, grown to 
Klettl 5 in C4 media and then 
diluted 1:10, were plated on non-
inducing plates immediately before 
gene induction and then every hour 
for four hours. The number of 
colonies on each plate was counted 
and divided by the number of 
colonies on the initial plates. 
Numbers greater than one indicate 
continued growth. Numbers less 
than one indicate cell death. B-gal 
is a control containing pET101lacZ. 
Data shows representative data 
from 3 experiments. 
stressed, the addition of gp40's possibly minor toxic effect was 
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overwhelming. There was a clear effect in this condition, which allowed 
for further experiments examining the effect on the rate of macromolecular 
synthesis after expression 
Figure 3.5: Effect of Gene Expression on Protein Synthesis 
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Figure 3.5: Effect of Gene Expression on 
Protein Synthesis Rates of protein 
synthesis were measured, by pulse-labeling 
with [methyl-3H] leucine, as a function of 
time after induction of the BL21 STAR 
culture containing pTY39, pTY40 or 
pET101lacZ, grown to Klett 15 and then 
diluted 1:10. Results were normalized by 
dividing the cpm at each time point by the 
cpm at time 0. B-gal is a control containing 
pET101lacZ. Graph shows representative 
data from 3 experiments. 
of the gene. 
Unfortunately, for RNA 
and DNA synthesis, the 
experiments varied 
greatly from one to 
another, making it difficult 
to interpret the results. 
For protein synthesis, a 
slow shutoff is observed, 
taking at least 2 hours for 
complete shutoff. Figure 
3.5 shows the results from one representative experiment where the rate 
of protein synthesis was measured. Because of the slow change in rate 
occurring over two hours, this shutoff is not believed to be the primary 
lethal mechanism. 
A potential explanation for the limited, conditional lethality of gene 40 
expression could be explained by the use of E.coli in the experiments. E. 
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coli was used due to difficulties cloning the genes into pPW19. pPW19 is 
not as tightly regulated, so lethal genes are often impossible to clone 
using this vector. We wanted to compare the effects of expression of all 
four genes with each other, so once one gene proved impossible to clone 
in pPW19, all future genes were cloned in pET101. Since E. coli is not the 
native host, gp40 may not be able to effectively bind with the E. coli 
version of its target. It is also possible that the gene products require 
another SP01 protein to function effectively. Since neither RNA nor DNA 
shutoff is completely deficient in the 40" mutants, at least one other gene 
product must be involved in the host RNA and DNA shutoff. The lack of 
this other gene product(s) may limit the effectiveness of gp40's ability to 
shutoff host DNA and RNA synthesis. 
3.3 Gene 39 regulates host DNA shutoff. 
As seen in figure 3.1, a nonsense mutant of gene 39 shows accelerated 
shutoff of host DNA synthesis compared to wild type (Laughlin data) in 
numerous repetitions of the experiment. While the wild type strain is able 
to "catch up" with the 39" strain by 12 minutes, at five minutes, a 
significantly higher amount of shutoff has occurred in the 39" mutant. 
Since removal of gp39 allows host shutoff to occur more quickly, gp39 
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must act to inhibit the shutoff of DNA synthesis. This indicates that gene 
39 likely plays a regulatory role in the host DNA shutoff process. 
3.4 Gp38 and gp39 regulate host RNA shutoff. 
Figure 3.6: Shutoff of Host RNA Synthesis 
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Figure 3.6: Shutoff of host RNA synthesis (38' 
,39\38'39"). Rates of RNA synthesis were 
measured, by pulse-labeling with [5-3H] uridine, as 
a function of time after infection by the indicated 
strains. The graph shows TCA-precipitable kcpm; 
i.e. cpm X 10 . Data is representative from 
several experiments. Data produced by Laura 
Laughlin. 
Gene 38 and 39 
mutants have a 
very limited RNA 
synthesis shutoff 
phenotype, but 
when both genes 
38 and 39 were 
mutated (see 
figure 3.6 and 3.2, 
Laughlin data), 
there was 
acceleration in 
RNA shutoff, similar to the acceleration seen with host DNA shutoff in the 
39 single mutant. This indicates that gps 38 and 39 must play a role in the 
regulation of RNA shutoff. Additionally, when either gp38 or 39 is not 
present, the other gene product must be able to compensate. Otherwise, 
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a greater effect would be seen in the single mutants. Gene 39, like gene 
40, is implicated in both RNA and DNA synthesis shutoff, with gp39 acting 
in a negative regulatory role. The simplest, but not the only, explanation 
for this data is that gp39 acts to restrain gp40. 
3.5 Gene 39 expression is lethal to uninfected bacterial cells. 
Indications of gp39's lethal nature were apparent from the start of 
experiments. Our initial attempts to clone gene 39 into pPW19 were 
unsuccessful. While pPW19 was the preferred vector as it could be 
expressed from both E. coli and B. subtilis, pPW19 does not fully repress 
gene expression. If gp39 is sufficiently lethal, even minimal expression 
will kill any cell that contains the plasmid, making cloning the gene 
impossible. A plasmid with tighter gene regulation, pET101, was 
successfully used to clone gene 39 (pTY39). As expected, expression of 
gene 39 in uninfected cells did indeed have a definite lethal effect in every 
condition tested (figures 3.3, 3.4). This shows that gene 39 is capable on 
interacting with a cellular target, an interaction that leads to death. This 
was interesting as the 39_ phenotype indicates that gp39 plays a 
regulatory role, not a causative one. 
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When the rate of macromolecular synthesis was monitored after induction 
of gene 39, DNA synthesis rates varied greatly from one experiment to 
another, making it impossible to draw any conclusion regarding the effect 
of gp39 on DNA synthesis. In both of the experiments measuring RNA 
synthesis, by two hours, the rate of RNA synthesis was greater than at the 
time of gene induction. This indicates that gp39 does not shutoff RNA 
synthesis. However, in all three experiments examining protein synthesis, 
within 30 minutes (the first time point measured) a significant drop in 
protein synthesis was seen (figure 3.5) Since no corresponding drop in 
RNA synthesis was observed, it appears as though the gene product 
specifically affects protein synthesis. For example, after 30 minutes of 
expression, RNA was being synthesized at a lightly faster rate then before 
induction (1.09 and 1.37 times the initial amount). However, protein 
synthesis dropped steadily (0.27, 0.52 and 0.61 times the initial amount). 
The drop in protein synthesis could also be explained as a result of a 
separate primary lethal mechanism. However, the very early shutoff 
makes this less likely. Further experiments, looking at earlier time points, 
should be performed to clarify this unusual result. 
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3.6 Gene 38 expression has a detrimental effect on uninfected E. coli 
cells, but not B. subtilis cells. 
While the 38" strain showed no significant phenotype when the rate of 
macromolecular synthesis was measured, colonies expressing gene 38, 
grown on inducing plates took nearly twice as long to grow as a culture 
containing pTY38R or pPW19lacZ grown on inducing plates. However, 
experiments monitoring the growth of a culture in liquid media (as defined 
in Ch 2.8) for three hours after induction of gene 38 were inconclusive, 
with each experiment giving different results. In the future, the 
experiments need to be repeated for more conclusive results. 
Interestingly, when gene expression was induced in B. subtilis, there was 
no difference in growth on inducing plates and non-inducing plates. This 
result was surprising since the gene product should be able to interact 
with its native host more specifically than with E. coli. Since the result was 
so unexpected, we tested several different strains of B. subtilis to see if 
this was a universal B. subtilis response to the gene or if my strain was 
naturally resistant. CB313(pTY38F), CB307(pTY38F), CB324(pTY38F), 
CB325(pTY38F), CB312(pTY38F), CB332(pTY38F) and CB369(pTY38F) 
all showed no difference between colonies grown on inducing plates and 
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non inducing plates, showing that the lack of response to gp38 in B. 
subtilis cells is probably a universal B. subtilis response. Determining the 
gp38's binding partners may help explain why the gene product is lethal in 
E. coli but not B. subtilis. 
3.7 Accelerated host-shutoff phenotypes caused by the 39" mutant, 
the 38'39'double mutant, and the 44"50"51 'triple mutant, are all 
suppressed by the 40' mutation. 
Based on the phenotype 
of the 39 and 40 
mutations, one hypothesis 
is that gp39 regulates 
gp40, while gp40 acts to 
shutoff RNA and DNA 
synthesis. If this is true, it 
is expected that a double 
mutant of 39' and 40" 
would have the same 
phenotype as the 40" mutant. As seen in figure 3.1, for host DNA shutoff, 
this was indeed what happened. As seen in figure 3.2, when RNA 
Figure 3.7 Shutoff of Host RNA Synthesis 
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Figure 3.7: Shutoff of host RNA 
synthesis (40", 44 50 51", 40"44"50"51). 
Rates of RNA synthesis were measured, 
by pulse-labeling with [5-3H] uridine, as a 
function of time after infection by the 
indicated strains. The graph shows 
TCA-precipitable kcpm; i.e. cpm X 10"3. 
Experiment has only been performed 
once. 
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synthesis was assayed, the triple mutant 383940" mostly suppressed the 
38 39" phenotype as well. 
As discussed in the background and shown again in figure 3.7, the 44"50" 
51" mutation also has the accelerated host RNA shutoff phenotype. 
Further evidence discussed in Ch1.6 shows that the gps44 and 51 are 
regulatory proteins. We wanted to determine if these gene products were 
involved in regulating gp40. If these gene products do act on gp40, we 
expected that adding the 40" mutation would suppress the 44 50 51", as it 
did with the 39" mutation. In the one experiment testing this quadruple 
mutant, this suppression was observed (figure 3.7). In this experiment, 
the triple mutant did not show as great an acceleration in RNA synthesis 
shutoff as seen in most other experiments (compare figure 3.7 to figure 
1.1), which makes the suppression effect less dramatic than expected. 
These experiments strengthen our argument that gp40 is a causative 
factor for host RNA and DNA shutoff and that gps44, 51, 38 and 39 
regulate gp40. 
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3.8 Gene 37 expression has a detrimental effect on uninfected E. coli 
cells. 
Despite gene 37's small size, we believe it still plays a role in host 
takeover. When E.coli containing pTY37 were grown on inducing plates 
for 48 hours at 37°C, the colonies appeared ragged and discolored 
(mottled) compared to cells grown on non-inducing media for the same 
amount of time. This difference in appearance after 48 hours of growth 
did not appear when DH5(pET101lacZ) cells were grown on inducing 
media. This indicates that gp37 is able to interact in some way with the 
cell. When an individual mottled colony grown on inducing media was 
selected and grown on antibiotic plates, both large and small colonies 
grew. The pattern was very similar to the satellite colonies seen when 
plating transformants, with a large colony surrounded by the small 
colonies. When we attempted to grow the small colonies on antibiotic 
plates, no growth was detected after 48 hours, indicating that these 
bacteria had lost their antibiotic resistance and therefore, their plasmids. 
The large colonies grew on antibiotic plates without any problems. The 
large colonies also were able to grow on inducing plates without any 
detrimental effect. The lack of the mottled effect indicates that these cells 
are now resistant to the gene. This suggests that the mottled effect may 
come from the presence of two genetically different bacteria- one wild type 
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lacking an antibiotic resistant plasmid and one mutated to be resistant to 
gene 37 expression. In the future, this observation may be useful for 
selecting resistant mutants. 
While the plating experiments indicate that gp37 is an active gene capable 
of performing some function, experiments testing the rate of 
macromolecular synthesis with the nonsense mutants (performed by 
Laura Laughlin) show no phenotype. When uninfected E. coli BL21 STAR 
cells were induced and rates of growth and macromolecular synthesis 
measured in C4 media, there was no observable effect. With the 48 hour 
growth required to see a clear difference between growth on inducing and 
non-inducing mutants, it is not surprising that all experiments looking at 
effects at 30 minutes to 3 hours showed no effect. 
3.9 Future experiments to test theoretical roles of 37-40 
The 4 genes are expressed from one operon and are likely translationally 
coupled. This increases the likelihood that they are all involved in the 
same process. The phenotypes from the nonsense mutants give strong 
evidence that gp40 is involved in shutting off RNA and DNA synthesis. 
Gp39 appears to restrain both RNA and DNA synthesis shutoff, while 
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gp38 restrains regulation of RNA synthesis shutoff. The simplest 
explanation is that all 4 gene products are involved in both RNA and DNA 
shutoff, with gps38 and 39 acting to restrain gp40's action. Gp37 probably 
also acts in this process in some currently undefined way. It is possible 
that the gene products interact with just one target, such as a 
chromosomal protein, which is capable of effecting both RNA and DNA 
synthesis. It is also possible that the gene products have multiple targets, 
one shutting off host RNA synthesis and the other shutting off host DNA 
synthesis. 
In order to clarify the roles of these genes, determining their binding 
partners is crucial. Knowing the binding partners would help answer the 
question of how they are shutting off RNA and DNA synthesis. It would 
also determine whether or not the gene products acted individually or 
formed a complex with each other. Attempts to purify the gene products, 
in order to perform binding experiments, are described in Ch4. Another 
useful experiment would be to repeat the lethality and macromolecular 
synthesis experiments using B. subtilis. This may give clearer results as 
the target will be the native target. This will require finding a vector for B. 
subtilis which can sufficiently repress gene expression. 
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Ch 4: Protein Purification Attempts of Gp39, Gp40 and 
Gp51 
4.1 Gp39 Purification Attempts 
In order to understand how gp39 functions, knowing what other gene 
products it binds to is critical. Pull down assays, co-immunoprecipitiaton 
and phage display assays would all be useful for obtaining this 
information. These experiments all require a purified protein. We focused 
most heavily on purifying gp39 because of its strong effect on the 
uninfected cells. 
4.1.1 Gp39 Expression 
Initial attempts to purify gp39 used the plasmid pTY39C, which is pET101 
with gene 39 inserted. A 6X C-terminal his tag is added to the protein by 
eliminating the termination codon. In purifying a protein, high expression 
is necessary. The plasmid was expressed in BL21* cells. In order to 
optimize expression levels, cells were shaken at 37°C at 100 rpm. 
Expression was induced at Klett 50 with 1 mM IPTG in one of the following 
medias: LB, L Broth, SM, Penassay, NY, VY or SOC. Aliquots were 
taken at 1, 2 and 4 hours. An additional experiment compared shaking at 
30°C, 37°C and 26°C. Maximum yield was seen when cells were grown in 
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Penassay for four hours after induction, at 37°C. Based on the strength of 
the gp39 band when visualized on a SDS-Page gel, this expression level 
was still not sufficient for protein purification. 
Since pTY39C did not have strong expression, gene 39 was expressed 
from a different vector, pET28b. This new plasmid, pTY39N places an N-
terminal his tag onto the protein. The cells were expressed in Rosetta2 
cells. The Rosetta2 cells express codons not typically expressed in E. 
coli. If a protein requires a codon not commonly used in E. coli, the 
Rosetta2 cells would allow an adequate expression level. Based on 
experience with pET28b in Rosetta2 cells, optimal expression usually 
occurs when induced with 1 mM IPTG with a culture at Klett 75-85. After 
induction, the cells were grown overnight at 25°C in LB medium, while 
shaking at 100 rpm. This protocol yielded high levels of gp39. 
4.1.2 Gp39 Solubility 
Gp39 was found in the insoluble fraction of the cellular extract. Proteins 
must be soluble in order to be purified. They can be insoluble for many 
different reasons, such as misfolding or the formation of inclusion bodies. 
While this problem can be solved by denaturing the protein, this 
introduces an additional problem of refolding the protein properly. In an 
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attempt to produce a soluble, native protein, numerous conditions were 
attempted, using the protocol defined by Bondos and Bicknell (Bondos 
and Bicknell, 2003). After cells were lysed, following the protocol outlined 
in the Bondos paper, the cellular extract was resuspended in Binding 
Buffer (Novagen) with one of the following additions: 10 mM DTT, 100 
mM NaCI, 0.2 M MgCI2) 1 M urea, 1 M L-arg, 10% glycerol, 0.5% NP40, 
10 mM EDTA, 1% TCA. After incubating for one hour at room 
temperature, the cellular extract was run over a Microcron concentrator 
with a 100 kDa molecular weight cut off (Fisher) which allowed only 
soluble proteins to pass through the filter. The solution was then run on a 
gel, with the amount of gp39 assessed visibly. Only the 10 mM DTT 
Binding Buffer solution showed any increase in gp39 solubility and this 
solubility increase was minimal. Since no conditions were found that 
allowed for high yield of native soluble protein, we denatured the cellular 
extract with 8 M urea. 
4.1.3 Gp39 Purification and Final Product 
After induction and overnight growth, proteins were extracted using the 
BugBuster kit (Novagen) following the company's protocols, with the 
addition of 8 M urea. The cellular extract was then run over a Nickel 
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column, following the Novagen protocol. The gp was eluted with Elute 
Buffer (Novagen) with 8 M urea (see figure 4.1). 
1 y 9 3 
Figure 4.1 Gp39 Purification 
and Loss of his tag 
accessibility: 15^1 samples 
run on 8-16% SDS page gel 
(Bio-Rad). Lane one is purified 
gp39 in urea. Lane two is the 
soluble fraction of purified 
gp39 after dialysis and lane 
three is the dialyzed sample 
after being run over a nickel-
chelate column. On the L 
(ladder) lane, the top purple 
band is 37.9 kd, with the next 
pink bad at 26.4kD. 
In order to refold the protein, the cells 
were dialyzed to remove the urea 
using a slow step down process. The 
protein solution was placed in 
Snakeskin Pleated Dialysis Tubing 
10,000 MWCO (Pierce), which was 
placed in Binding Buffer with a 
progressively lower dilution of urea. 
The solution was allowed to dialyze for 
3 hours at 4°C at each dilution of urea. 
The 8 M urea was dialyzed to 6 M, 
then 5 M, then 4 M, then 3 M, then 2 
M, then 1 M, then 0.5 M and then 0. 
At this point, we attempted to run the 
purified, refolded protein over a nickel 
column. Unfortunately, the protein did not bind to the column. When the 
purified protein was centrifuged, the protein was still found in the soluble 
portion based on gel visualization (see figure 4.1). This could indicate that 
58 
the his tag was folded into the protein so that it was no longer accessible. 
Since the his tag should be accessible, this suggests that the protein is not 
refolding properly. Testing binding properties with an unfolded protein 
would produce no useable data. Additionally, we planned to use the his 
tag in performing the pull down assays. Therefore, a new purification 
scheme must be determined. In future attempts, a tag on the C-terminal 
may refold properly, or a longer linker between the protein and the his tag 
may be successful. Alternately, a different tag, such as a maltose binding 
protein or a GST tag, could be used for purification. 
4.2 Gp40 Purification 
We desired a purified gp40 in order to perform the binding assay 
experiments discussed in section 4.1 for gp39. Gene 40 was inserted into 
pET101, adding a C-terminal his tag, to create pTY40C. The gp was 
expressed under the same conditions as pTY39C and like pTY39C, had 
problems with low yield and insolubility. Gp40 was tested with all the 
same conditions as gp39; however, none produced higher yield or greater 
solubility. Purification attempts did not proceed beyond this point. 
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4.3 Gp51 Purification Attempts 
As discussed in Ch1. 6, one hypothesis we wanted to test was that gp51 
and gp44 bind to RNAP to regulate gene expression. In order to test if 
Gp51 does indeed bind to RNAP, a pure protein was needed. In addition 
to testing if gp51 binds specifically to RNAP, pull down assays could be 
performed to determine currently unsuspected binding partners. Also, an 
in vitro transcription system could be devised, in order to look at the effect 
of gp51 on transcription. Different promoters could be used to determine 
the specific effect on early genes or delayed early genes. While 
expression and solubility of gp51 were not a problem, an additional 
complication arose in the form of an extra gene product (see Ch 4.4). 
4.3.1 Gp51 Expression 
Gene 51 was inserted into pET101, with the termination codon removed 
allowing for the inclusion of 6X C-terminal his tag (plasmid designated 
pAZ51). Gene expression was induced in BL21* cells, with 1 mM IPTG 
when the culture reached Klett 75-85. The cells were grown in LB 
medium for 2 hours at 37°C, shaking at 120 rpm. Additional conditions, 
such as temperature (room temperature and 30°C) and time after 
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induction (1 ,2 ,4 and 24 hours) were also tested. Two bands appeared 
with induction, one at the expected size and one around 10 kd. Figure 
4.2, lane 3 shows an expressed culture, while lane 4 is pET101 with no 
insert, also induced with 1 mM IPTG. The two bands are indicated by 
black arrows. The top band is gp51, while the lower is an additional his 
tagged protein. This extra protein must be removed in order to obtain a 
pure protein, but the reason for its presence is worth studying at a later 
time. 
4.3.2 Gp51 Purification 
Induced cells were harvested using BugBuster (Novagen). The cell 
extracts were run over a nickel column, following manufacturer's protocol 
(Novagen). The protein was eluted with 1 M imidazole. Figure 4.2, lane 
one, shows this eluent. The additional protein fragment could be 
separated by running the cell extract over a DE52 (Whatman) column, as 
the smaller fragment runs through the column, while gp51 does not. 3.5 g 
of dry resin was resuspended in 30 mis 0.1 M Tris pH 8.0. The solution 
was allowed to settle for 15 minutes and then decanted. This was 
repeated until the pH was 7.5. The settled precipitant was then 
resuspended in 30 mis of Tris buffer (50 mM Tris pH 8.5, 0.5 mM EDTA). 
The solution was again allowed to settle and the supernatant decanted. 
The resin was then resuspended into 10 mis of Tris buffer. One ml of 
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resin was used for purification of protein from 1.5 grams of pelleted cells. 
Cellular extract was loaded onto the column and allowed to run through. 
The column was then washed with 32 mis of Tris buffer. The protein was 
eluted with 1.0 ml of Tris buffer with 1 M NaCI. 
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Figure 4.2 Purification of gp51: 
The upper arrow indicates the 
location of gp51, lower arrow 
indicates gp51 fragment. Lane 1 
shows the result of an extract of 
cells expressing gp51 after being 
run over a nickel-chelate column. 
Lane 2 shows an extract of cells 
containing pETlOl with no insert, 
run over a nickel-chelate column. 
Lanes 3 and 4 show the soluble 
fraction of cells expressing gp51 
and cells containing an empty 
vector respectively. Lane 5 is the 
ladder. The lowest three bands 
are approximately 6.9, 21 and 29 
kD. 
While this column was capable of 
separating gp51 from the second 
protein, the eluent still contained 
contaminating proteins. It was hoped 
that by running the eluent over a nickel 
column, the remaining contaminants 
would be removed. Unfortunately, the 
elution buffer from the DE52 column 
does not react well with the nickel 
column. Alternatively, the Elution Buffer 
for the nickel column does not react well 
with the DE52 column. When the 
columns were run sequentially, it 
resulted in very low yields. Therefore, in 
the future, a dialysis step needs to be added between the two columns. 
Hopefully, this will fix the low yields and provide a pure protein. 
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4.4 Additional Gene Within Gene 51 
The additional fragment that was expressed and co-purified with gp51 also 
contained a 6X C-terminal his tag, indicating that it is expressed from 
within gene 51. The fragment was submitted for N-terminal sequencing to 
UTMB Bimolecular Resource Facility following their outlined protocols. 
Their results indicated that the fragment was indeed expressed from the 
last third of gene 51. In addition, the same protocol was followed to 
confirm that the other band was indeed gp51. Our results clearly show 
high levels of expression (see figure 4.2), indicating that this gene product 
may play an important role in SP01 infection. Since this gene was not 
known prior to these experiments and has such high expression, future 
studies looking at this gene are needed. 
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Ch 5: Gene 2.21 and 25.1 Mutant Screen 
We believe genes 2.21 and 25.1 may be involved in the regulation of 
immediate early and delayed early genes (see Ch1). By studying mutants 
of these genes, we can examine the effects of the genes. For example, if 
the genes are the causative factor for delayed early gene expression, then 
the mutants will show a significant decrease in delayed early expression. 
5.1 General Protocol 
5.1.1 Homologous Recombination 
In order to create a nonsense mutant, homologous recombination is used 
(see figure 5.1). When DNA is replicated, two sections of DNA that are 
homologous can line up, allowing for a crossing over event to occur. In 
our mutants, we create a plasmid containing a section of SP01 DNA. A 
mutation can be introduced into the SP01 insert, as described in later 
sections. If a reciprocal double crossover occurs between the SP01 
chromosome and the plasmid, one on each side of the mutation, the 
mutation would be swapped into the SP01 genome. The plasmid would 
then have wild type SP01 DNA instead of the mutated version it had 
originally carried. Homologous recombination is naturally occurring, so 
simply infecting bacteria containing a plasmid with SP01 is sufficient. 
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However, it occurs at a relatively low frequency. In prior experiments, a 
successful recombination occurred only once in every thousand individual 
phage infections. 
I 1 
Figure 5.1 Homologous Recombination: In the figure, 
the light purple represents SP01 DNA cloned into a 
plasmid. The yellow star represents an introduced 
mutation. The dark purple represents the SP01 DNA not 
cloned in the plasmid. A crossing over event before and 
after the mutant site will transfer a mutation from the 
plasmid to SP01. Increasing the homologous DNA 
before and after the mutation allows for more bases 
where crossing over can occur, increasing the frequency 
of mutation. 
5.1.2 Mutant Plasmid Guidelines 
In creating the mutant plasmid, there are several parameters to follow. 
Prior experiments, using genes found in the terminal redundancy, showed 
that homologous recombination occurred when 63 bases where present 
upstream and downstream of the mutation. A stop codon introduced at 
the beginning of the gene would essentially knockout the gene. Since this 
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mutation is potentially lethal to the phage, a B. subtilis suppressor strain, 
CB313 is used. In this suppressor strain, the TAA and likely also the TAG 
stop codon is read as a lysine. This means that if the first lysine in the 
gene is mutated then, in the suppressor strain, the gene can be translated 
as wild type (Mulbry et al, 1989). Once the mutant is created, the effect of 
the mutation can be studied by infecting a non suppressor strain (in our 
lab CB10) with the mutant strain. In order to make it easier to find the 
mutation, AAG is mutated to TAA or AAA to TAG. This change of two 
bases allows for easier differentiation between mutant and wild type when 
screening with an oligonucleotide probe. The base between the two 
mismatched bases, while not mutated, is still unable to bind to the wild 
type probe because of the mismatched pairs next to it. With 3 
mismatched bases, the difference in binding rates between the mutant 
probe and mutant DNA versus the wild type probe and mutant DNA are 
different enough to effectively distinguish between mutant and wild type 
DNA. 
5.1.3 Homologous Recombination Protocol and Initial Mutant Screen 
In order to perform the recombination, B. subtilis CB313 cells containing a 
plasmid with the mutated gene were infected with wild type SP01 at an 
MOI of one. Fifteen minutes after infection, the infected cells were diluted 
1:50. After 45 minutes, 0.02 mis of chloroform per ml of infected culture 
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were added. The lysate was then plated for plaques, using CB313 grown 
to mid exponential phase, lysate and 15.4 g/L TBAB top agar. Plates 
were grown overnight at 37°C, then moved to room temperature for 8-24 
hours. After that, they were stored at 4°C for 1-4 days. Plaque lifts were 
performed as described in Ch 2.10. 
5.1.4 Hybridization 
The membranes were then placed in hybridization tubes at 35°C, with 16 
ml prehybridization solution [5X Denhardts (1g/100ml BSA, 1g/100ml 
Ficoll 400, 1g/100ml Polyvinyl Pyrolidine(sigma PVP-10)), 6X SSC, 0.5% 
SDS and 1 mM EDTA] for 4 hours in Robbins Scientific Model 400 
Hybridization Incubator, rotating at 4 rpm at 35°C. While the membranes 
were incubating, labeled probes were prepared. While the radioactive 
probes can be used for up to a month after preparation, fresh probes are 
ideal as the radioactivity decays. 10 pm of primer was added to 10 pi of 
10 mc/ml y-32P-ATP (MP Biomedicals), 4 pis of T4 Polynucleotide Kinase 
(PNK) (NEB) and 1X T4 PNK buffer, using H20 to bring the volume up to 
30 pis. The mixture was incubated for 45 minutes in a 37°C water bath. 
The enzyme was deactivated by a 20 minute incubation at 65°C and 40 
pis of TE buffer added. The mixture was then run over a G-25/50 
Sephadex column to purify it. 2.0 X 107 counts per minute of labeled 
probe were added to 26.4 mis of hybridization solution (5X Denhardts, 6X 
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SSC, 0.5% SDS). The prehybridization solution was removed and 
replaced with the probe and hybridization solution. The probes were 
allowed to hybridize overnight in a hybridization chamber set for 35°C, 
rotating at 4 rpm. After the overnight hybridization, the filters were washed 
twice for 5 minutes with 6X SSC at room temperature. They were then 
wrapped in saran wrap. Photographic film was exposed to the filters and 
the film developed. 
5.1.5 Controls 
In addition to the plaque lift membranes which were being screened, 
additional membranes were used as controls. One membrane was 
probed with a wild type specific probe. Since the wild type and mutant 
probes should have similar binding conditions and the probes were 
prepared in the same way at the same time, successful binding of the wild 
type probe to wild type plaque lifts would show that the probes were able 
to bind to the DNA under the conditions used. It also confirms that the 
plaque lift successfully picked up the DNA. While ideally, this would be 
done using mutant plaques, this is obviously not possible because if we 
had the mutant, we wouldn't need to do this experiment. While we could 
use the mutant plasmid in E.coli, this would be a very flawed control. 
When bacterial colony lifts are screened, they have a significantly stronger 
signal than plaque lifts. This could be due to differing levels of DNA being 
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transferred to the membrane. Based upon optimal exposure times for 
colony lifts versus plaque lifts, the signal is at least 30 times stronger. 
Therefore, we would expect a strong positive from a colony lift, even at 
times and conditions where we would not see a strong positive using a 
plaque lift. 
A second control used was a blank membrane. This blank membrane 
shows that there is nothing else in the experiment causing a signal. Since 
we wanted to make sure that we saw any potential positive plaque, we 
often exposed the membranes long enough that the small amounts of 
non-binding radioactive probes were able to produce a signal. We were 
able to expose the films for a shorter time and still see a strong signal 
using wild type probes against wild type plaques with no signal on the 
blank membranes, but we wanted to make sure that no potential mutant 
was overlooked. 
The final controls were the experimental plates probed with the mutant 
probe. Since we expected a low frequency of mutation, these plates were 
expected to be blank, with the exception of a few spots. This showed that 
the mutant probe did not bind strongly with wild type plaques. If we had 
seen most of the plaques, it would indicate that the probes were not 
/ 
69 
binding specifically enough to distinguish between mutant and plaque 
DNA. 
5.1.6 Secondary Screening of Putative Mutants 
After exposing the film and checking the controls, putative positive 
plaques were then picked. The plugs were resuspended in 1 ml of LB. 
These lysates were then plated so that each plate had approximately 200 
plaques. Membranes were prepared and probed as described above. For 
any plaque that again produced a strong signal when probed with a 
mutant probe, the single plaque was picked and resuspended in 1 ml of 
LB. 5 pis of this lysate was amplified by PCR using the SP01 protocols 
discussed in Ch 2.6. No additional preparation was needed to free the 
SP01 DNA from the protein capsid for PCR amplification. It was assumed 
that the high temperature in the PCR protocol is enough to break the 
capsid and make the DNA accessible. This DNA was then sequenced by 
Lonestar or Seqwright sequencing companies. 
5.1.7 Multiple Recombination Rounds 
Unfortunately, following the above described protocol did not yield any 
mutants (more details discussed below). We therefore altered the 
recombination protocol in an attempt at increasing the frequency of 
mutation. CB313, containing the appropriate plasmid, was infected with 
the appropriate lysate, as described above. These cells were then 
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allowed to fully lyse. This lysate was then used to infect a new culture of 
CB313 (which also contained the appropriate plasmid). In theory, the 
lysate would have the original mutants, as well as newly formed mutants. 
In a perfect situation, the second lysate would have twice as many 
mutants as the original recombined lysate. Ten more rounds of this were 
performed. The lysate from the final round was then screened for mutant 
plaques. 
5.2 Proof of Principle: Gene 44 Mutant 
In order to show that the screening method works at distinguishing mutant 
phage from wild type phage, plates were prepared of plaques with a 
mutated gene 44, a wild type version of gene 44 and mixture of the two. 
As seen in figure 5.2, when the mutated plaques were probed with a 
mutant specific probe (LYS3UAG), strong spots were seen, but when the 
wild type probe (LYS3AAA) was used, no plaques were seen. For wild 
type plates, the wild type probe had a strong signal, whereas the mutant 
probe had no signal. On the mixed plates, half of the plaques were visible 
when probed with wt probe and the other half when probed with mutant 
probe. This shows that the detection system does work. 
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Figure 5.2 Gene 44 Mutant Detection: The film shows membranes probed 
with either the 44 mutant probe (LYS3UAG) or 44 wt probe (LYS3AAA). 
Membrane A is a mixture of wt and 44" phage strains. Membrane B is 44". 
Membrane C is wt. Membrane D is a mixture of wt and 44". Membrane E is 
44". Membrane F is wt. Membrane G is a blank membrane. Membranes A, 
B, C and G are probed with the radioactively labeled LYS3UAG, while 
membranes D, E and F are probed with the radioactively labeled LYS3AAA. 
The film was exposed to the membranes for 15 hours. Spots appearing on E, 
G and C are background contamination, perhaps caused by air bubbles in the 
filter. 
5.3 p25.1mutA Recombination Attempt 
An initial plasmid (p25.1wtA) consisting of the full 25.1 gene inserted in the 
expressed orientation into pPW19 (see Table 2.3 and figure 5.3) was 
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A: p25.1mutA Insert 
88977: 
25.1 88990: 
stop Insert 
codon end 
B: p25.1mutB Insert 
88977: 88990: 
25.1 Insert 
stop end 
codon site 
C: p2.21mutA Insert 
D: p2.21mutB Insert 
25360: Mutation 
26049: 2 6 0 7 0 1 
2 21 Insert 
stop 691(1 
codon si"® 
Figure 5.3 Plasmid Inserts: These cartoons compare the 4 mutated 
inserts created in this chapter: p25.1mtA (A), p25.1mtB (B), p.2.21mtA (C) 
and p2.21mtB (D). Diagrams are not to scale. The pink section 
represents the gene, while the purple sections are bases upstream and 
downstream of the gene. The blue star on a green background represents 
the introduced mutation. 
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mutated to create p25.1 mutA. 61 bases upstream of the gene were also 
included. The entire promoter region was excluded. Since this gene is an 
early gene, including the promoter would allow for gene expression in 
bacteria. Since the two gene products that are homologous to 25.1 (44 
and 51) were both very lethal, expression of this gene was likely also 
lethal. p25.1 wtA was mutagenized using the Stratagene Quick Change 
Site-Directed Mutagenesis Kit, following the provided protocol. 
25.1TAGmut and its reverse complement (25.1TAGRC) primers were 
used, creating a stop codon (TAG) instead of a lysine (AAA) at the ninth 
amino acid. This insert includes 85 bases upstream of the mutation and 
613 bases downstream of the mutation, which is more than the 63 bases 
required in our prior experiments. 
We attempted to create both a single mutant and a quadruple mutant of 
44"50"51"25.1". Because of the homology between 44 and 51 and the 
similarities in the expected functions (discussed in Ch 1), we wanted to 
see the effect of mutating all 4 genes. In order to create the quadruple 
mutant, Aruna Sampath's 44 50 51" knockout strain was used to infect 
CB313(p25.1MutA). To create a single mutant, wild type lysate was used 
to infect CB313(p25.1MutA). The first recombination attempt for the single 
mutant was performed by Sean Murray and no MOI was recorded. I then 
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screened approximately 10,000 plaques from this recombination, with no 
mutant found. For the quadruple mutant, the recombination experiment 
had an MOI of 0.4. As with the single mutant, approximately 10,000 
plaques were screened with no mutants detected. 
5.4 Ability of probes 25.1mutA and 25.1wtA to distinguish mutant 
and wild type DNA 
In order to show that the probes were capable of distinguishing between 
mutant and wild type DNA, cultures of CB313(p25.1mutA) were plated, as 
were wild type plaques. The colonies and plaques were then lifted using 
the plaque lift protocol in Ch 2.10 and probed as described in Ch 5.1. 
While preferably, this experiment would be performed with both wild type 
and mutant in bacteria, the E. coli cultures containing the plasmid were not 
stored properly and were therefore unavailable for this experiment. Figure 
5.4 shows that the wild type probe [25.1(8377)wt] produced a strong 
signal when probing wild type plaques, but a weak signal when probing 
colonies with the mutant plasmid. Considering the increased signal 
normally noted when colony lifts are performed, this shows a very strong 
ability to distinguish wild type from mutant. The mutant probe 
[25.1(8377)mut] had strong binding to the colonies containing the 
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mutant 
plasmid, but 
essentially no 
binding to the 
wild type 
plaques. This 
shows that 
25.1(8377)wt is 
capable of 
binding to the 
mutant DNA. 
Since both 
membranes 
from wild type 
plaque lifts 
were exposed 
the same 
amount of time and the 25.1(8377)wt probe versus wild type plaques 
produced a strong signal while the 25.1(8377)mut probe versus wild type 
Figure 5.4 Probes 25.1 mutA and 25.1 wtA: This 
is a film exposed to membranes A-D. A and C are 
probed colony lifts from CB313(pTY25.1mutA). B 
and D are probed plaque lifts of wt SP01. A, and D 
were probed with 25.1 (8337)mut, while B and C 
were probed with 25.1(8337)wt. 
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plaques did not, it is likely that the mutant probes are capable of 
distinguishing effectively between mutant and wild type. 
5.5 p25.1mutB: Recombination Attempt 
Since we were unable to find a mutant using the p25.1mutA plasmid, we 
created a new plasmid, with a slightly different mutation (see figure 5.3). 
Like the initial plasmid, the new wild type plasmid (p25.1wtB) consisted of 
the full 25.1 gene inserted into pPW19. However, for p25.1wtB, the insert 
is in the unexpressed orientation. For this plasmid, 89 bases upstream of 
the gene were also included. While the -10 promoter site was included, 
the -35 site was not. This is sufficient to prevent gene expression in the 
bacterial cell. p25.1wtB was mutagenized using the Stratagene Quick 
Change Site-Directed Mutagenesis Kit, following the provided protocol. 
The primers 25.1 TAA and its reverse complement 25.1TAARC were used, 
creating a stop codon TAA instead of a lysine (AAG) at the 35th amino 
acid. This provides 191 bases upstream of the mutation and 533 bases 
downstream of the mutation for crossing over to occur. This plasmid 
(p25.1mutB) was believed to have a higher chance of creating a mutant 
due to the additional bases. Furthermore, the TAA mutation is established 
in the literature to be well suppressed in CB313. While we believe that the 
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TAG mutation is also suppressed in this strain, this is not an established 
fact in the literature. By changing which codon we mutated we hoped that 
the mutation would be more strongly suppressed and therefore more likely 
to survive. 
Attempts were again made to produce both a single and quadruple (44 50" 
5125.1") mutant. For these attempts, the extended, multiple recombination 
experiment described in Ch5.1.7 was used. For the final round of 
recombination, the MOI for the wild type phage infection of 
CB313(p25.1mutB) can not be determined. Plates plated 5 minutes after 
infection had slightly more colonies (7% more) than those plated 
immediately prior to infection. The triple mutant infected 
CB313(p25.1mutB) at an MOI of 1.9. For each lysate, between 10,000 
and 12,000 plaques were screened with no positive mutants. 
5.6 Ability of probes 25.1 mutB and 25.1 wtB to distinguish mutant 
and wild type DNA 
With the creation of a new mutant, new probes were also needed. To 
confirm that these new probes worked effectively, E. coli containing either 
p25.1mutB or p25.1wtB was plated, colony lifts were performed and the 
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Figure 5.5 Probes 25.1mutB and 25.1wtB: 
This is a film exposed to membranes A-E. A 
and B are probed colony lifts from 
DH5(pTY25.1mutB). C and D are probed 
colony lifts from DH5(pTY25.1wtB). E is a 
blank membrane. A,C and E were probed 
with 25.1 (8449)mut, while B and D were 
probed with 25.1(8449)wt. Film was 
exposed to the membranes for 20 minutes. 
membranes probed as 
described above. 
While colony lifts do 
routinely give 
significantly higher 
signal, two colony lifts 
from plates with a 
similar number and 
size of colonies should 
yield similar amounts 
of DNA. Since at this 
point, the question is 
whether or not the 
probes can distinguish 
between wild type and 
mutant DNA, as long 
as the amounts of DNA 
are similar, the 
experiment should yield usable results. As seen in figure 5.5 the mutant 
probe [25.1(8449)mut] creates a strong, consistent signal only when the 
mutant DNA is present. While some wild type colonies do bind with 
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25.1(8449)mut probe, the difference in signal is still large enough to 
distinguish between mutant and wild type DNA. The wild type probe 
[(25.1(8449)wt] has a strong signal only when probing wild type DNA and 
almost no signal when probing mutant DNA. 
5.7 p2.21mutA: Recombination Attempt 
p2.21wtA includes the full 2.21 gene in unexpressed orientation, inserted 
into pPW19 (see figure 5.3). Only 29 bases upstream of the gene were 
included. The strongest putative promoter is a middle gene promoter, 
which would not be expressed from uninfected bacterial cells; however, 
two putative weak early promoters are also present. While there was no 
reason to suspect that this gene had a lethal effect, the putative promoters 
were still not included in order to avoid this potential complication. 
p2.21wtA was then mutagenized using Stratagene Quick Change Site-
Directed Mutagenesis Kit, following the provided protocol. The primer 
2.21TAGmut and its reverse complement 2.21TAGRC were used, creating 
a stop codon (TAG) instead of a lysine (AAA) at the 14th amino acid. This 
insert included 61 bases upstream of the mutation and 675 bases 
downstream of the mutation. The plasmid was designated p2.21mutA. 
80 
The recombination experiment vi/as performed as described in Ch5.1, with 
only one round of recombination. In the first recombination experiment, 
the wild type phage infected CB313(p2.21mutA) with an MOI of 1.5. 
Approximately 5000 plaques were screened, with no mutants found. The 
recombination experiment was repeated, this time with an MOI of 1. 
10,000 plaques from this lysate were screened with no mutants 
discovered. 
5.8 Ability of probes 2.21 mutA and 2.21 wt to distinguish mutant and 
wild type DNA 
Plates of E. coli containing either plasmid p2.21 mutA or p2.21 wtA were 
grown. Colony lifts were performed as described above and the filters 
probed with either wild type probe [2.21(5393)wt] or mutant probe 
[2.21(5393)mut], As shown in figure 5.6, these probes can distinguish 
effectively between probe and wild type as strong signal occurs only when 
2.21(5393)mut probes mutant colony lifts and 2.21(5393)wt probes wild 
type colony lifts. 
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Figure 5.6 Probes 2.21itlutA and 2.21 wtA: This is a 
film exposed to membranes A-D. A and B are probed 
colony lifts from DH5(pTY2.21 mutA). C and D are 
probed colony lifts from DH5(pTY2.21wtA). B, and D 
were probed with 2.21 (5393)mut, while A and C were 
probed with 2.21(5393)wt. 
5.9 p2.21 mutB Recombination Attempts 
After failing to find a positive mutant, p2.21wtB was created by inserting 
the complete 2.21 gene in the unexpressed orientation into pPW19 (see 
figure 5.3). Additional bases upstream of the gene, including all three 
putative promoters were included in this plasmid. Since we were able to 
clone the gene successfully, this indicates that gene 2.21 either is not 
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lethal or the two early putative promoters are too weak to produce enough 
of the gene product to kill the cell. Primers 2.21 TAA and its reverse 
complement 2.21TAARC were used to mutagenize the gene using the 
Stratagene Quick Change Site Directed Mutagenesis kit. The 
mutagenized plasmid, p2.21mutB, contains 360 bases upstream of the 
mutation and 698 bases downstream of the mutation. 
CB313 containing p2.21 mutB was infected with wild type phage, following 
the multiple recombination protocol defined in Ch5.1. The MOI for the 
final round of recombination was 1.6. Approximately 11,000 plaques were 
unsuccessfully screened. 
5.10 Ability of probes 2.21mutB's and 2.21 wtB to distinguish 
mutant and wild type DNA 
The same protocol for testing the probes for the first 2.21 mutant was 
used to test the new probes effectiveness. E. coli containing plasmid 
p2.21mtB or p2.21wtB were plated and probed with either [2.21(5360)mut] 
or [2.21(5360)wt]. As shown in figure 5.7, the mutant probe 
[2.21(5360)mut] was effective in distinguishing mutant from wild type, 
producing a strong signal when probing mutant DNA and almost no signal 
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Figure 5.7 Probes 2.21 mutB and 2.21 wtB: 
This is a film exposed to membranes A-E. A 
and B are probed colony lifts from 
DH5(pTY2.21 mutB). C and D are probed 
colony lifts from DH5(pTY2.21wtB). B and 
D were probed with 2.21 (5360)mut, while A 
and C were probed with 2.21(5360)wt. Film 
was exposed to the membranes for 20 
minutes. 
when probing wild type 
DNA. Unfortunately, 
the wild type probe 
[2.21(5360)wt] did not 
distinguish between 
mutant and wild type 
DNA, producing strong 
signal when probing 
both mutant and wild 
type colony lifts. 
However, the wild type 
probe is not necessary 
for the mutant screen, 
so the screening was 
performed as planned. 
5.11 Overview of Results 
For all three mutants (25.1", 2.21", 44"50"51"25.1") desired, two different 
constructs were attempted, with over 10,000 plaques screened for each. 
Since we expected 1 mutant for every 1000 wild type plaques, 10 mutant 
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plaques would have been expected for each mutant. Since we instead 
found none, there must be an explanation for the lack of mutations. It is 
possible that our expectation of 1 mutant in 1000 is inaccurate. Both of 
the genes we attempted to mutate are not in the terminal redundancy. 
Our expectation of 1 mutant in a 1000 comes from prior work mutating 
genes in the terminal redundancy. It is possible that the region of DNA 
containing genes 25.1 and 2.21 have a different, lower frequency of 
mutation than the terminal redundancy. If the frequency of mutation was 1 
in 10,000, missing the one positive plaque is much more likely than 
missing 10 positive plaques. We had no control to ensure that 
homologous recombination was occurring at all in our experiment, so it is 
possible that the rate is zero. 
Another possible explanation for the lack of mutants could be that these 
genes are essential genes. While CB313 does suppress the mutation, it 
does not fully eliminate it. So, while the gp will still be produced, it will not 
be produced at wild type levels. If the amount of gene product produced 
falls beneath the amount required for successful phage infection, the 
mutant plaque will never appear in a screening. Since this was not a 
problem when mutating genes 44 and 51, we did not expect this to be a 
problem for gene 25.1. For gene 2.21, we expected that even with 
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decreased level of the sigma factor, the infection would still be able to 
occur. If the plaque is extremely unhealthy and small, it could also be 
overlooked. However, during our screening, we were extremely inclusive 
in putative mutant selection in order to minimize this possibility. 
A third explanation is that the mutation selection process was flawed. 
Ideally, the controls limit the possibility of total experimental failure. The 
probes are clearly capable of binding to the mutant or wild type DNA. 
Plaque lifts are transferring DNA, which can be detected with wild type 
probes. The only major factor not controlled for would be that the mutant 
probes, and only the mutant probes, can not bind to mutant DNA from 
plaques. This is unlikely since there is nothing distinctly different between 
the mutant and wild type probes to explain why the mutant probes would 
not be able to bind to plaque DNA when they could bind to the mutant in 
the plasmid. 
5.12 Future Work 
In the future, different methods of mutant construction should be 
attempted. For example, instead of trying to create a conditional mutant, 
the entire gene could be knocked out. If the gene was replaced with GFP, 
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this would be easier to screen for. If the mutation is required for infection 
to occur, an additional expression vector could be added to the B. subtilis 
strain during production and maintenance of the mutant strain. Gene 
expression would be induced at the same time as infection. While gene 
expression may be lethal, during infection the cell is already exposed to 
many lethal gene products. 
Another avenue of research is examining the effect of gps 2.21 and 25.1 
on an in vitro transcription/translation system. For this, the gene products 
must be purified. They could then be added to the in vitro transcription 
system and the effects monitored. By using promoters specific to 
immediate and delayed early genes, the effect of regulation on specific 
gene types can be measured through the in vitro transcription system. 
Different sigma factors and potential regulators could also be tested. 
Binding assays looking at whether or not the gene products bind to RNAP 
specifically could be performed as well. This approach would provide 
significant information about the gene products function without the need 
for a mutant. 
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